Biblio
Export 1713 results:
Author [ Title
Filters: First Letter Of Last Name is C [Clear All Filters]
“Non-Fibrillar Oligomeric Amyloid-β within Synapses.”, J Alzheimers Dis, vol. 53, no. 3, pp. 787-800, 2016.
, “Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.”, J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
, “Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.”, J Alzheimers Dis, vol. 54, no. 2, pp. 717-21, 2016.
, “A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 681-691, 2018.
, “A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 681-691, 2018.
, “NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1427-1443, 2018.
, “NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1427-1443, 2018.
, “No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
, “Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
, “NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 775-787, 2017.
, “New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1145-1163, 2018.
, “New Gold in Them Thar Hills: Testing a Novel Supply Route for Plant-Derived Galanthamine.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1321-1325, 2017.
, “New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
, “New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.”, J Alzheimers Dis, vol. 64, no. s1, pp. S529-S534, 2018.
, “New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1317-1337, 2020.
, “Neuropsychological Predictors of Long-Term (10 Years) Mild Cognitive Impairment Stability.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1703-1711, 2018.
, “Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
, “Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
, “Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case Report.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1363-1369, 2018.
, “Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity.”, J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
, “Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity.”, J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
, “Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
, “Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
, “Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.”, J Alzheimers Dis, vol. 66, no. 1, pp. 11-23, 2018.
, “Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.”, J Alzheimers Dis, vol. 66, no. 1, pp. 11-23, 2018.
,